Top Research Reports for Merck, Equinor & Illinois Tool Works

In this article:

Monday, December 11, 2023

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Equinor ASA (EQNR) and Illinois Tool Works Inc. (ITW). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Merck have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-2.2% vs. +7.3%). The company is witnessing generic competition for several drugs, and rising competitive pressure, mainly on the diabetes franchise, will continue to be overhangs on the top line. There are concerns about Merck’s ability to grow its non-oncology business ahead of Keytruda’s loss of exclusivity later in the decade.

Nevertheless, Merck’s products like Keytruda and Gardasil have been driving sales. With continued label expansion into new indications, particularly earlier-stage launches, Keytruda is expected to remain a key top-line driver.

Animal health and vaccine products are core growth drivers. Merck boasts a strong cancer pipeline, including Keytruda, which should drive long-term growth. Merck is investing in M&A activity to strengthen its pipeline.

(You can read the full research report on Merck here >>>)

Shares of Equinor have gained +11.5% over the past six months against the Zacks Oil and Gas - Refining and Marketing industry’s gain of +16.7%. This integrated energy company has a global footprint spanning across more than 30 countries. In Europe, it ranks as the second-largest supplier of natural gas. It is proactively directing investments into renewable energy projects to tackle the issues posed by climate change.

Equinor anticipates a significant expansion of its renewable production capabilities, targeting a range of 4-6 GW by 2026, with further ambitions to elevate this capacity to 12-16 GW by 2035.

However, its balance sheet has a notable level of debt exposure compared with industry peers, which could potentially affect its financial flexibility. The company also reported weak third-quarter earnings due to reduced production volumes and lower prices of liquids and gas in Norway. Its ambitious capital budget poses a challenge. As such, the stock warrants a cautious stance.

(You can read the full research report on Equinor here >>>)

Shares of Illinois Tool Works have outperformed the Zacks Manufacturing - General Industrial industry over the past year (+13.9% vs. +13.7%). The company is benefiting from improving supply chains and underlying demand. Strength in the Automotive OEM segment, driven by favorable customer mix and product line simplification activities is aiding the company’s performance.

Decreasing cost of sales and enterprise initiatives are supporting Illinois Tool’s margin performance. The company’s efforts to add shareholder value are encouraging. However, persistent weakness in the Test & Measurement and Electronics segment due to softness in semiconductor-related business in the North American region is concerning.

The decline in the specialty films, consumer packaging, specialty films and strength films businesses within the Specialty Products segment is an added woe. Given Illinois Tool’s international presence, foreign currency headwinds are weighing on its top line.

(You can read the full research report on Illinois Tool Works here >>>)

Other noteworthy reports we are featuring today include Motorola Solutions, Inc. (MSI), Arthur J. Gallagher & Co. (AJG) and Atlassian Corp. (TEAM).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Keytruda to Remain Merck's (MRK) Key Top-Line Driver

Equinor (EQNR) Set to Benefit From Clean Energy Initiatives

Automotive OEM Unit Aids Illinois Tool (ITW) Amid Forex Woes

Featured Reports

Solid Order Trends, Portfolio Strength Buoy Motorola (MSI)
Per the Zacks analyst, Motorola is likely to benefit from solid demand for video security products and related services, backed by a diligent execution of operational plans and healthy growth dynamics

Improving Fees and Commissions Aid Arthur J. Gallagher (AJG)
Per the Zacks analyst, Arthur J. Gallagher is poised to grow on improving fees and commissions that in turn is driving organic revenues growth. However, rising expenses weighing on margin concerns.

Atlassian (TEAM) Gains On Rising Hybrid Working Tool Demand
Per the Zacks analyst, Atlassian is benefiting from the rising demand for remote working tools amid the hybrid work trend and accelerated digital transformation.

Teleflex (TFX) Gains From Interventional Arm, FX Woes Stay
The Zacks Analyst is impressed with Teleflex gaining from a diversified Interventional Access portfolio, including MANTA, balloon pumps and the emerging structural heart. Yet, FX woes are a concern.

Build-To-Order Model Aid Toll Brothers (TOL), Macro Woes Ail
Per the Zacks analyst, Toll Brothers is benefiting from its Build-To-Order model and affordable luxury communities. However, supply constraint and high-cost environment are concerning.

International Operations Aid FTI Consulting (FCN), Cost High
Per the Zacks analyst, FTI Consulting's strong international operations make it an excellent partner for global clients, generating continued revenue growth. Rising investment costs is a concern.

Loan Growth Aids First Horizon (FHN), Rising Costs Ail
First Horizon's (FHN) top line should continue to benefit from high rates along with rising loans and deposits. Yet continued investments in technology keep bottom-line under pressure.

New Upgrades

Flex's Performance Benefits From Continued Demand Momentum
The Zacks analyst is optimistic about strong demand for Flex's solutions in the automotive and industrial verticals. Subdued IT spending amid global macro weakness remains a headwind.

Pilgrim's Pride (PPC) Benefits From Strong Mexico Operations
Per the Zacks analyst, Pilgrim's Pride looks well placed on its Mexico business strength. In third quarter, Mexico operations sales surged 30.5% driven by factors like enhancements in live processes.

Fidelity (FIS) Rides on Strategic Buyouts & Digitization
Per the Zacks analyst, multiple strategic buyouts are helping Fidelity National enhance its capabilities. Also, it is well-positioned to benefit from the global digital transformation.

New Downgrades

Reduced Demand and Trade Conflicts to Ail Enphase (ENPH)
Per the Zacks analyst, the unfavorable demand environment will impact Enphase Energy's topline. U.S.-China trade conflicts and supply-chain constraint will impact production and income.

WestRock (WRK) Remains Troubled by Slowdown in Volumes
Per the Zacks analyst, WestRock is witnessing a decline in volumes as customers are rebalancing their inventory, and spending has been muted due to weak economic conditions.

Weakness in Communication Market Ails Analog Devices (ADI)
Per the Zacks analyst, Analog Devices is suffering sluggishness in communication end market due to ongoing inventory corrections.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report

Merck & Co., Inc. (MRK) : Free Stock Analysis Report

Motorola Solutions, Inc. (MSI) : Free Stock Analysis Report

Arthur J. Gallagher & Co. (AJG) : Free Stock Analysis Report

Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report

Equinor ASA (EQNR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement